X-Dosage as a Latent Variable in Microglial Aging

Question: How do X-linked genes and sex chromosome dosage shape microglial transcriptional states and immune reactivity in the aging brain?

Answer

Taken together, these papers support a two-step model in which sex chromosome dosage reaches microglia mainly through the epigenetics of X inactivation rather than through cell-intrinsic dosage sensing. First, escape from X inactivation places a subset of immune-relevant X genes at two functional doses in female cells, but this escape is lineage-restricted and appears weakest in myeloid cells, which bounds how large a female-specific microglial dosage effect can be at baseline. Second, aging erodes the silencing machinery that maintains the inactive X — H3K27me3 redistribution, X-inactivation-center remodeling, and XIST/EZH2 dysregulation — so that an initially modest dosage difference becomes a progressive, female-biased amplifier of interferon and inflammatory tone in late life. The predicted phenotype is exactly what the aging and amyloid literature reports: female microglia enriched for disease-associated and interferon-stimulated states, conserved from mouse to human. The thesis of this survey is therefore that X-dosage is a real but indirect and age-gated modifier of microglial state, operating substantially through X-linked transcriptional regulators of autosomal immune programs and through the aged tissue environment, and that no retrieved study yet establishes a cell-autonomous X-dosage effect on aged microglia by direct manipulation.

Escape from X inactivation supplies immune gene dosage, but myeloid lineage escape is comparatively low

Allele-resolved single-cell phasing of human immune cells reveals a lineage-specific escape program in which lymphoid cells escape X inactivation more broadly than monocytes, with matching gains in inactive-X chromatin accessibility and female-biased expression [17]. In human glioblastoma, however, the inactive X is directly implicated in microglial biology: female and male tumor-associated microglia mount different inflammatory responses, with female cells showing stronger interferon signaling and cytotoxic T-cell interactions, and sex-chromosome genes expressed from the Xi drive those differences [11]. The magnitude of escape, not merely female-biased expression, is what predicts female-biased output: stronger escape from X inactivation in non-pseudoautosomal X genes is associated with more pronounced female-biased expression, while female-biased expression on the X is a poor proxy for escape [18]. Single-cell analysis of human cortex expands the known escapee list substantially and attributes the largest sex differences in expression to X-Y gametologs, cell-type-specific X- and Y-linked biases, and escape [27].

Aging destabilizes X inactivation, converting a static dosage difference into a progressive female-biased amplifier

Single-nucleus multi-omics of the mouse hypothalamus identifies female-specific X-chromosome changes as a prominent feature of aging, including altered X-inactivation-center signals and an overall increase in X-chromosome gene expression and accessibility in immune cells and neurons, alongside increased abundance and genome-wide redistribution of H3K27me3 onto the inactive X in females [1]. The same repressive mark is mechanistically tied to disease: in Alzheimer's cortex, reduced EZH2 impairs H3K27me3 on the inactive X, disturbing silencing and elevating the X-linked RNA export factor THOC2, with XIST accumulating abnormally in the cytoplasm [12]. EZH2 is independently nominated, together with HIF1A and CEBPB, as a candidate regulator of the microglial interferon-γ program associated with accelerated neuronal aging [2]. X-chromosome dosage compensation itself operates gene by gene at both RNA and protein levels rather than as a chromosome-wide switch, consistent with a graded rather than binary dosage readout [13]. In blood, X-inactivation skew increases with age and after early menopause, and is a stable but drifting cellular phenotype, indicating that the mosaic substrate on which escape acts is itself age-dependent [16]. Adult X-chromosome hypomethylation in females with multiple sclerosis is strongly enriched at non-escape genes normally subject to inactivation, supporting direct investigation of inactive-X regulation as a disease-relevant axis [21].

Female microglia in the aged and diseased brain converge on an interferon-high reactive state

Microglia are the principal cell type underlying sex differences in the aging mouse brain, with females showing greater disease-associated microglia proportions, greater reactivity, and enhanced interferon-related signaling, and comparison with ROSMAP snRNA-seq shows conservation of sex-biased transcriptional responses and shared regulatory networks [3]. In 5xFAD mice, sex rather than estrous-cycle stage drives the microglial transcriptome, with female microglia enriched for glycolytic, antigen-presentation, DAM/MGnD, and interferon-signaling genes [28]. A sex-dependent type I interferon signature is selectively enriched in female AD brain and mirrored in APP/PS1 mice, and inhibiting cGAS-STING reduces pathology and preserves cognition in females [23]. Bulk multi-region transcriptomics likewise finds more extensive late-stage remodeling in females, characterized by stronger immune activation and greater suppression of mitochondrial metabolism [7]. At the level of endophenotype associations, 73% of sex-specific gene-endophenotype associations are found in females, and four X-linked genes show significant sex-by-gene interactions with amyloid, tau, or cognition [30].

X-linked regulators act largely through autosomal immune programs and the aged tissue environment

Most sex-biased expression is not directly explained by X-chromosome number: only 7.7% of sex-biased genes are directly attributable to sex chromosome number, whereas 79% are targets of transcription factors that are themselves sex-biased, and the strongest candidates (FOSL1, ZNF730, ZFX, ZNF726) are regulated by X-chromosome number [15]. CIZ1 illustrates the same indirection in immune cells: genes escaping inactivation in females, including DDX3X, require CIZ1 in males to maintain parity, and loss of this single regulator triggers sex-specific remodeling of large autosomal domains in B cells [20]. Isogenic XX, XY, and XO human pluripotent lines show that X-haploinsufficiency deregulates predominantly autosomal targets, mediated by Y genes whose X homologues escape inactivation [19]. Critically, the aged environment rather than cell-autonomous programming appears to dominate microglial aging: young donor-derived myeloid cells in aged brains acquire aging phenotypes while old cells in young brains adopt youthful profiles, with STAT1 signaling and NK-cell-driven interferon as necessary drivers [5]. X-linked microglial genes also act through non-immune-effect pathways, as microglial Fmr1 loss impairs lysosomal function and reduces progranulin to drive neuronal degeneration [9], and X-linked ATRX deficiency produces type I interferon upregulation through a cGAS-dependent mechanism [14].

Where dosage is manipulated directly, chromosomal effects are real but frequently subordinate to gonadal and environmental factors

Systematic dissociation of gonadal and sex chromosome dosage contributions to brain structure shows gonadal effects dominating across an expanded map of sex-biased volume, with sex chromosome dosage reinforcing or counteracting gonadal effects in a region-specific manner and jointly shaping sex-biased cellular expression in the cerebellum [24]. In the medial septum, by contrast, sex chromosome-associated effects show elevated relevance compared with sex hormones in driving sex-biased gene expression [26]. In microglia specifically, Four Core Genotypes testing of a male-biased autism-like phenotype attributes the bias to sex hormones rather than non-Sry sex chromosome genes, with estrogen receptors undetectable in microglia at postnatal day 14, implying indirect hormonal action on microglia [29]. Sex-divergent responses to microglial depletion in 21-month-old mice are likewise regionally and molecularly asymmetric, with males showing 295 differentially expressed proteins versus 34 in females and proteomic changes dissociating from mRNA changes [4]. Multi-omic decomposition of the sex effect in aged human cortex yields an axis driven by canonical sex-chromosome genes but enriched epigenetically for plasticity pathways, with a female-biased shift toward precursor-like oligodendrocyte states rather than a microglial readout [6]. Even at the brain borders, immune signatures are enriched in females and border-associated macrophages differ by sex between compartments [25].

Conflicts and gaps

The direction of the aging effect on X silencing is unresolved. Hypothalamic aging shows increased H3K27me3 abundance and redistribution onto the inactive X in females [1], whereas Alzheimer's cortex shows reduced EZH2 and impaired H3K27me3 on the inactive X [12]; whether this reflects a normal-aging trajectory that disease reverses, or region- and cell-type-specific divergence, is not tested. The size of the cell-autonomous myeloid dosage effect is also contested: allele-resolved phasing places monocytes among the lowest escapers [17], yet Xi-expressed genes are claimed to drive microglial inflammatory differences in glioblastoma [11] — a tumor context that may not generalize to aging parenchyma. The relative weight of chromosomal versus gonadal contributions is directly contradictory across brain phenotypes [24] [26] [29]. Most consequentially, no retrieved study manipulates X dosage in aged microglia: the strongest aging X-chromosome dataset profiles mixed hypothalamic immune cells rather than microglia [1], no XXY, XO, or XY* model is aged with microglial single-cell readouts, and the mosaicism of female microglia with respect to which X is active has not been resolved in aging despite available de novo phasing methods [22]. Human X-chromosome association atlases nominate escape genes such as RBBP7 in excitatory neurons, not microglia [10], leaving the microglial X-linked effector set unidentified.

What would change the answer

Applying de novo active-X inference and long-read haplotype phasing [22] [17] to aged female microglia would convert the mosaic female brain into an internal, allele-resolved dosage experiment and directly measure whether escape widens with age in the myeloid lineage. Aging X-dosage series — XO, XX, XXY, and XY* mice alongside Four Core Genotypes — with microglial snRNA-seq and interferon challenge at 3, 12, and 24 months would separate X number from Y number and from gonadal effects, extending the design already validated in structure and septum [24] [26]. Microglia-specific manipulation of Xi maintenance — conditional Ezh2 or Xist perturbation, or gene-targeted CRISPR activation of silenced Xi alleles as demonstrated for Nexmif [8] — would test sufficiency and reversibility rather than correlation. Isogenic XX, XY, and XO pluripotent lines with stable dosage compensation [19], differentiated to microglia and engrafted into aged chimeric hosts, would isolate X dosage from autosomal background and from the aged environment that appears to dominate microglial aging [5]. Finally, allelic testing of specific X-linked candidates already implicated in microglial immune control — Tlr7-pathway dosage, Fmr1, ATRX — in aged females would establish which escapees actually carry the interferon phenotype.

References

[1] Yu, D., Osipov, I., Hassell, L.-A., Shwartz, N. A., Hajdarovic, K. H., Marin, H., Webb, A. E.. "Single-cell transcriptomic and epigenomic analysis reveals X-linked sex differences in aging mouse hypothalamus". bioRxiv. 2026-09-14T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.08.750001

[2] Lim, C. M., Vendruscolo, M.. "Microglia as transcriptional pacemakers of neuronal aging heterogeneity across individuals". bioRxiv. 2026-04-08T00:00:00.000Z. URL: https://doi.org/10.64898/2026.04.05.716624

[3] Cox, J. E. J., Poljanska, E., Ray, S., Forsgren, M., Ko, S., Swiergiel, P., Wright, Z., Thomas, M. A., Freeman, W. M., Delpirou Nouh, C., Rice, H. C., Ocanas, S. R.. "Female microglia show heightened responses to aging and amyloid pathology in mice and humans". bioRxiv. 2026-10-19T00:00:00.000Z. URL: https://doi.org/10.64898/2026.10.13.758897

[4] Beganovic, A., Flotho, M., Li, J., Guldner, I. H., Reich, M., Wahl, V., Graf, S., Donate, P., Rishik, S., Dashdorj, E. D. D., Ludwig, N., Mueller, R., Iram, T., Wyss-Coray, T., Wagner, V., Keller, A.. "Sex-divergent responses to microglial depletion suggest distinct regulatory dependencies in the aged brain". bioRxiv. 2026-09-08T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.03.745468

[5] Gizowski, C., Popova, G., Shin, H., Mader, M. M., Craft, W., Kong, W., Shibuya, Y., Wranik, B. J., Fu, Y. C., Depp, C., Lin, T. D., Martin-McNulty, B., Yoo, Y., Tai, P.-H., Hingerl, M., Leung, K., Atkins, M., Fong, N., Jogran, D., Wendorff, A., Hendrickson, D., Gillich, A., Chang, A., Stevens, B., Wernig, M., Hahn, O.. "Heterochronic myeloid cell replacement reveals the local brain environment as key driver of microglia aging". bioRxiv. 2025-09-07T00:00:00.000Z. URL: https://doi.org/10.1101/2025.09.02.673859

[6] Whalley, J. P., Hunsberger, H. C., Bennett, D. A., Lamar, M., Peterson, D. A., Stutzmann, G. E.. "Aged brain multi-omic integration captures immunometabolic and sex variation". bioRxiv. 2025-10-21T00:00:00.000Z. URL: https://doi.org/10.1101/2025.10.10.681695

[7] Pal, A., Arif, S., Karthikeyan, I., Waisberg, E., Guarnieri, J. W.. "A mitochondrial-immune axis drives the transcriptomic transition from brain aging to Alzheimer's disease". bioRxiv. 2026-06-05T00:00:00.000Z. URL: https://doi.org/10.64898/2026.06.03.729900

[8] Merth, K., Man, H.-Y.. "Reactivation of the X-linked Nexmif Gene Corrects Mosaic NEXMIF Deficiency in Heterozygous Female Mice". bioRxiv. 2025-12-01T00:00:00.000Z. URL: https://doi.org/10.1101/2025.11.29.691251

[9] Li, H., Choi, J. J.-Y., Huang, E. J., Xu, B.. "Loss of FMRP in microglia promotes degeneration of parvalbumin neurons and audiogenic seizures via progranulin insufficiency". bioRxiv. 2025-07-12T00:00:00.000Z. URL: https://doi.org/10.1101/2025.07.09.663876

[10] Cook, N., Zeng, Y., Yang, C., Jiang, Z., Wang, T.-C., Le Guen, Y., Cody, K., Johnson, M., Zhang, R., Merritt, V. C., Hauger, R. L., The VA Million Veteran Program,, FinnGen,, Koran, M. E., Mormino, E. C., Gordon, B., DeCasien, A., Andrews, S. J., Dumitrescu, L., Archer, D. B., Hohman, T. J., Pottier, C., Cruchaga, C., Sherva, R., Logue, M., Napolioni, V., Greicius, M. D., Belloy, M. E.. "An APOE*4-Informed Genomic Atlas of the X Chromosome in Alzheimer's Disease". medRxiv. 2026-05-06T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.05.26352461

[11] Tharp, M. E., Han, C. Z., Talukdar, M., Balak, C. D., Fitzpatrick, C., O'Connor, C., Preissl, S., Buchanan, J., Nott, A., Escoubet, L., Mavrommatis, K., Gupta, M., Schwartz, M. S., U, H. S., Jones, P. S., Levy, M. L., Gonda, D. D., Ben-Haim, S., Ciacci, J., Barba, D., Khalessi, A., Coufal, N. G., Chen, C. C., Glass, C. K., Page, D. C.. "The inactive X chromosome drives sex differences in microglial inflammatory activity in human glioblastoma". bioRxiv. 2025-05-19T00:00:00.000Z. URL: https://doi.org/10.1101/2024.06.06.597433

[12] Sen, S., Mukhopadhyay, D.. "XIST Self-regulates its Association with THOC2 and the Nuclear Epigenetic Machinery via miR-186 in Alzheimer's disease". bioRxiv. 2026-06-27T00:00:00.000Z. URL: https://doi.org/10.1101/2025.10.05.680468

[13] Allsop, R. N., Boeren, J., Tan, B. F., Merzouk, S., Poovathingal, S., van Ijcken, W., Demmers, J. A., Mira Bontenbal, H., Gontan Pardo, C., Gribnau, J., Pasque, V.. "X-chromosome upregulation operates on a gene-by-gene basis at RNA and protein levels". bioRxiv. 2025-08-19T00:00:00.000Z. URL: https://doi.org/10.1101/2025.06.18.660324

[14] El-Daher, M.-T., White, E. L., Grimes, G., Zhu, G., Fellas, A., Tait, T. A., Uggenti, C., Blair, N., Nita, E., Gautier, P., Dunn-Davies, H., Glen, S., Dhir, S., Rodero, M. P., Rice, G. I., Seabra, L., Clark, R., Fawkes, A., Marsh, J. A., Livingston, J. H., Wassmer, E., Naik, S., Vogt, J., Isidor, B., Tillotson, R., Lepelley, A., Revy, P., Gibbons, R. J., Crow, Y. J.. "ATRX Deficiency Drives Aberrant Type I Interferon Signalling Through cGAS-Dependent Transcriptional Dysregulation". bioRxiv. 2025-11-21T00:00:00.000Z. URL: https://doi.org/10.1101/2025.11.19.685761

[15] Jones, A. G., Dalapati, T., Connelly, G. G., Wang, L., Schott, B., SAN ROMAN, A. K., Ko, D. C.. "Biological sex affects gene expression and functional variation across the human genome". medRxiv. 2025-04-14T00:00:00.000Z. URL: https://doi.org/10.1101/2024.09.03.24313025

[16] Roberts, A. L., Osterdahl, M. F., Sahoo, A., Pickles, J., Franklin-Cheung, C., Wadge, S., Mohamoud, N. A., Morea, A., Amar, A., Morris, D. L., Vyse, T. J., Steves, C. J., Small, K. S.. "Diminished sex hormone levels influence the risk of skewed X chromosome inactivation". medRxiv. 2026-04-22T00:00:00.000Z. URL: https://doi.org/10.64898/2026.04.20.26351303

[17] Kavanagh, D., Steel, A., King, H. E., Vieira, H. G. S., Kumar, K. R., Masle-Farquhar, E., King, C., Skvortsova, K., Weatheritt, R. J.. "Lineage-specific X chromosome inactivation escape and skew underlie sex-biased immune gene dosage and deleterious variant exposure". bioRxiv. 2026-08-31T00:00:00.000Z. URL: https://doi.org/10.64898/2026.08.26.739472

[18] DeCasien, A. R.. "Escape from X inactivation varies across genes and tissues and shapes sex-biased sex chromosome gene expression". bioRxiv. 2025-12-22T00:00:00.000Z. URL: https://doi.org/10.64898/2025.12.19.695225

[19] Meleckyte, R., Varsally, W., Zohren, J., Eriksson, J., Incitti, T., Starnes, L., Pointon, A., Hicks, R., Powell, B. E., Turner, J.. "A human induced pluripotent stem cell toolbox for studying sex chromosome effects". bioRxiv. 2025-03-03T00:00:00.000Z. URL: https://doi.org/10.1101/2025.02.28.640277

[20] Guglielmi, E., Monge-Lozano, R., Pearson, J. F., Pais, F. S., James, S. R., Hewitson, J. P., Kent, D. G., Coverley, D., Ainscough, J. F. X.. "Sex-specific lymphoid lineage differentiation is modulated by CIZ1". bioRxiv. 2026-08-27T00:00:00.000Z. URL: https://doi.org/10.64898/2026.08.26.747233

[21] Calnin, T., Maltby, V. E., Burnard, S. M., Xavier, A., Simpson-Yap, S., van der Mei, I., Broadley, S., Taylor, B. V., Butzkueven, H., Ponsonby, A.-L., Scott, R. J., Jagodic, M., Jokubaitis, V. G., Lechner-Scott, J., Lea, R. A.. "X-chromosome methylation patterns in females with multiple sclerosis". medRxiv. 2026-10-14T00:00:00.000Z. URL: https://doi.org/10.64898/2026.10.13.26365261

[22] Jiang, J. L. H., Gillis, J.. "XC-ID: De novo identification of the active X chromosome in single-cell RNA-seq". bioRxiv. 2025-12-06T00:00:00.000Z. URL: https://doi.org/10.64898/2025.12.05.692676

[23] Lopez-Lopez, V., Iniesta, G., Galan-Ganga, M., Exposito-Coca, A., Bhojwani-Cabrera, A., Guillot-Fernandez, M., GIRALT, A., Lopez-Atalaya, J. P.. "Sex-dependent interferon signaling drives female-biased vulnerability in Alzheimer's disease". bioRxiv. 2025-09-10T00:00:00.000Z. URL: https://doi.org/10.1101/2025.08.22.671724

[24] Lerch, J. P., Shin, J., Ellegood, J., Hrncir, H., Nieman, B., MacKenzie-Graham, A. J., Yang, X., Arnold, A. P., Raznahan, A.. "Gonadal and sex chromosomal contributions to sex differences in mammalian brain organization". bioRxiv. 2026-01-10T00:00:00.000Z. URL: https://doi.org/10.64898/2026.01.10.698782

[25] Kaiser, K., Silva-Vargas, V., von Allmen, L., Sakoparnig, T., Doetsch, F.. "Choroid plexus sex differences in secretory signalling and immune compartments". bioRxiv. 2025-08-19T00:00:00.000Z. URL: https://doi.org/10.1101/2025.08.15.670566

[26] Shin, J., Blencowe, M., Yang, X., McQuillen, C., Hrncir, H., Chen, X., Diamante, G., Ahn, I. S., Zhang, G., Arnold, A. P., Mackenzie-Graham, A., Lerch, J., Raznahan, A.. "Relative contribution of gonads and sex chromosomes to sex differences in cell-type gene expression in the mouse medial septum and sex-biased disease risk". bioRxiv. 2025-12-11T00:00:00.000Z. URL: https://doi.org/10.64898/2025.12.08.693050

[27] DeCasien, A. R., Auluck, P., Liu, S., Marenco, S. R., Cookson, M. R., Raznahan, A.. "Sex effects on gene expression across the human cerebral cortex at single cell resolution". bioRxiv. 2025-07-04T00:00:00.000Z. URL: https://doi.org/10.1101/2025.06.30.661781

[28] Rodriguez, L. C., Noyes-Martel, N., Becker, J. L., Majewska, A. K., O'Banion, K. M.. "Sex, not estrous cycle stage, drives differences in the microglial transcriptome in the 5xFAD mouse model of amyloidosis". bioRxiv. 2025-04-03T00:00:00.000Z. URL: https://doi.org/10.1101/2025.03.28.646050

[29] Niu, C., An, J. J., Masterson, H. V., Xu, B.. "Sexual dimorphism of autism-like phenotypes in microglial eIF4E overexpression mice". bioRxiv. 2026-09-07T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.03.748596

[30] Seto, M., Clifton, M., Gomez, M. L., Coughlan, G., Gifford, K. A., Jefferson, A. L., De Jager, P., Bennett, D. A., Wang, Y., Barnes, L. L., Schneider, J. A., Hohman, T. J., Buckley, R. F., Dumitrescu, L.. "Sex-specific Associations of Gene Expression with Alzheimer's Disease Neuropathology and Ante-mortem Cognitive Performance". bioRxiv. 2025-01-02T00:00:00.000Z. URL: https://doi.org/10.1101/2025.01.02.631098

How this survey was made

This survey answers one question: “How do X-linked genes and sex chromosome dosage shape microglial transcriptional states and immune reactivity in the aging brain?”

We keep our own collection of recent preprints and refresh it every day from bioRxiv, medRxiv, arXiv, PsyArXiv, SocArXiv and ChemRxiv. For each survey, we search that collection for recent work and keep the strongest matches: papers that use the same terms as the question, and papers on the same topic in different words.

The text was written from the titles and abstracts of those papers; the full texts were not read. Statements that draw on a particular paper are marked with a number in brackets. The reference list just above is the 30 papers whose work this text draws on, chosen from the 117 papers those searches returned; the rest of the shortlist is not printed. It is not a complete review of everything published on the question.

Treat this as a starting point and a reading list, not a peer-reviewed review. The searches behind this survey ran on October 22, 2026 and covered work from the previous two years.